|
Market Cap (16-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 7 November 2022, 8:22. The announcement is marked as price sensitive, and is 17 page(s) in length and 1.74MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 2.074% short sold according to ASIC data. It was ranked the 134th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| ZIRCON Ph III Imaging Study - Top-Line data presentation | 7 November 2022, 8:22 |
| ZIRCON Ph III Imaging Study - Positive Top-Line Results | 7 November 2022, 8:22 |
| Notification regarding unquoted securities - TLX | 26 October 2022, 10:45 |
| Notification of cessation of securities - TLX | 25 October 2022, 10:45 |
You must be logged in to post a reply.
Telix Pharmaceuticals 